New Bird Flu Cases Identified in Pennsylvania and Utah, States USDA

Kathleen Kinder
Kathleen Kinder

Updated · Apr 25, 2022

SHARE:

Scoop.market.us is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more.
close
Advertiser Disclosure

At Market.us Scoop, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Scoop. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

On Saturday, USDA declared that new bird flu cases have been detected in commercial flocks of chicken in Pennsylvania and a backyard flock in Utah. The outbreak is now thought to have spread to more than 30 states in the country.

Earlier this month, the federal debt. Said it was considering vaccines as an option to safeguard poultry from the deadly flu, as the country faces its most harmful outbreak since 2015. Since February, this outbreak has wiped out well over 20 million chickens and turkeys among commercial flocks.

Samples from flocks belonging to both Pennsylvania and Utah were tested. The samples from Pennsylvania were tested at the Pennsylvania Veterinary Laboratory, and those from the Utah flocks were tested at the Utah Veterinary Diagnostic Laboratory, a part of the National Animal Health Laboratory Network, the Department of Agriculture said in a statement on Saturday.

USDA said that both Federal and state officials were working together on facilitating additional monitoring and testing in areas close to these infected flocks.

US officials have said that recent highly pathogenic avian influenza cases do not pose an immediate public health concern.

Previously, the United States avoided vaccinations out of fear that importers would ban US poultry shipments because they could not distinguish between infected and vaccinated birds. The United States is the second-largest exporter of poultry meat in the world. In 2020, the value of US poultry and poultry product exports reached $4.2 billion globally.

Bird flu has affected poultry in Europe and Asia and North America. USDA is presently working with other countries on vaccine options.

Trade has suffered, as importers like China have blocked imports from many US states over the outbreak.

The United States has the strongest avian influenza surveillance program in the world. Through their ongoing wild bird surveillance program, the Animal and Plant Health Inspection Service (APHIS) collects and tests large numbers of samples from wild birds in the North American flyways. APHIS is working closely with state animal health officials in Pennsylvania and Utah on joint incident responses. State officials quarantined the affected premises, and birds on the properties will be depopulated to prevent the spread of disease. Birds from these flocks will not enter the food system. In addition to monitoring for avian influenza in wild bird populations, APHIS monitors for this virus in commercial and backyard birds.

It is not uncommon to detect avian influenza in wild birds as avian influenza viruses circulate freely in those populations without the birds appearing sick. In addition to monitoring for avian influenza in wild bird populations, APHIS monitors for the virus in commercial and backyard birds. The recent detections of the Eurasian H5 strain of highly pathogenic avian influenza in wild birds and domestic poultry in the United States. Bird owners have been asked to review their biosecurity practices and stay vigilant to protect poultry and pet birds from this disease.

SHARE:
Kathleen Kinder

Kathleen Kinder

With over four years of experience in the research industry, Kathleen is generally engrossed in market consulting projects, catering primarily to domains such as ICT, Health & Pharma, and packaging. She is highly proficient in managing both B2C and B2B projects, with an emphasis on consumer preference analysis, key executive interviews, etc. When Kathleen isn’t deconstructing market performance trajectories, she can be found hanging out with her pet cat ‘Sniffles’.